- This tool estimates bleeding risk on anticoagulation (HAS-BLED).
- It does not estimate stroke risk — that is the job of CHA2DS2-VASc (tool #525).
- In atrial fibrillation care the two scores are calculated together: one weighs the danger of clots, the other the danger of bleeding.
- A high HAS-BLED score is a prompt to review modifiable factors, not a reason to withhold anticoagulation on its own (ESC guideline position).
1 · Tick the factors that apply
2 · Your HAS-BLED result
Score breakdown
- No factors selected yet.
Modifiable factors to review
Tick factors above — any modifiable ones you select will appear here with suggested actions to discuss with a clinician.
3 · Bleeding rate by score (cohort data)
Major bleeding = bleeding requiring hospitalisation, a haemoglobin drop, or transfusion. Rates are bleeds per 100 patient-years in the Pisters 2010 Euro Heart Survey derivation cohort (n = 3,978), as reproduced by Lip et al. 2011. Cohort estimates — not personal predictions.
The has bled score table below doubles as a has bled score chart: has bled score interpretation at a glance — for example, has bled score 0 → 1.13, has bled score 1 → 1.02, has bled score 2 → 1.88, has bled score 3 → 3.74, has bled score 4 → 8.70, and has bled score 5 → 12.50 bleeds per 100 patient-years. Because the cohort is warfarin-era, treat it as a warfarin bleeding risk calculator first, and only a rough doac bleeding risk calculator for patients on direct oral anticoagulants.
| Score | Risk group | Bleeds / 100 pt-yrs | What it means |
|---|---|---|---|
| 0 | Low | 1.13 | Low bleeding risk — anticoagulation generally preferred when stroke risk warrants it. |
| 1 | Low | 1.02 | |
| 2 | Moderate | 1.88 | Moderate risk — correct modifiable factors, consider closer follow-up. |
| 3 | High | 3.74 | High risk — review every modifiable factor and monitor closely. A high score alone is not a reason to withhold anticoagulation (ESC). |
| 4 | High | 8.70 | |
| 5 | High | 12.50 | |
| 6–9 | Very high | n/a | No reliable estimate: score 6 had 2 patients (0 bleeds); scores 7–9 had 0 patients in the cohort. Interpret as very high; floor shown is 12.50. |
4 · The modifiable four — where the score can actually move
Five HAS-BLED points are fixed history (renal, liver, stroke, bleeding, age). Four can potentially be improved — this is the whole point of calculating HAS-BLED in clinic. These four are the has bled modifiable risk factors: correcting any of them lowers both the score and the real bleeding risk behind it.
| Factor | What to review with a clinician |
|---|---|
| H — Uncontrolled hypertension | Optimise blood-pressure control; SBP ≥160 mmHg is the scoring threshold. |
| L — Labile INR | Stabilise anticoagulation: adherence, interacting drugs/diet, monitoring frequency, or agent review. |
| D — Bleeding-risk drugs | Reassess ongoing need for concomitant antiplatelet or NSAID therapy. |
| D — Alcohol (≥8 drinks/week) | Reduce alcohol intake. |
Each corrected factor lowers the score — and, more importantly, the real bleeding risk behind it.
5 · Use it together with CHA2DS2-VASc
HAS-BLED alone never decides about blood thinners. It is always read against stroke risk. Use cha2ds2 vasc has bled together for the full picture — clinicians often shorthand the pairing as hasbled vs chadsvasc. When you see a has bled high score, remember the has bled score–anticoagulation relationship is often misunderstood: a high number flags review, not refusal. If you arrived from another hasbled score mdcalc alternative, the difference here is the modifiable-factor checklist above and this pairing guide.
| Question answered | HAS-BLED | CHA2DS2-VASc |
|---|---|---|
| What does it measure? | 1-year major-bleeding risk on anticoagulation | Annual stroke risk without anticoagulation |
| High score means… | Review modifiable factors; monitor closely | Anticoagulation generally favoured |
| Typical pairing | High stroke score + low bleeding score → anticoagulate. High stroke score + high bleeding score → often still anticoagulate, but fix every modifiable factor first and follow up closely. Low stroke score + high bleeding score → the risk–benefit conversation changes. | |
Calculate the other half of the decision with our CHA2DS2-VASc stroke-risk calculator (tool #525).
6 · Worked examples
Example A — 4 points (high)
68-year-old man with atrial fibrillation, uncontrolled hypertension (SBP 172), on warfarin with unstable INRs, takes ibuprofen most days for arthritis.
H (1) + L (1) + E (1) + D-drugs (1) = 4 → high, 8.70 bleeds/100 pt-yrs. Modifiable: blood pressure, INR stability, NSAID review.
Example B — 0 points (low)
55-year-old woman with atrial fibrillation, blood pressure well controlled, normal renal and liver function, no prior stroke or bleeding, stable on her regimen, no regular alcohol or NSAIDs.
No factors present = 0 → low, 1.13 bleeds/100 pt-yrs.
Example C — 6 points (very high, estimate capped)
74-year-old with prior ischaemic stroke, prior gastrointestinal bleed, chronic kidney disease (creatinine 230 µmol/L), on aspirin, drinks ≥8 drinks/week.
S (1) + B (1) + A-renal (1) + E (1) + D-drugs (1) + D-alcohol (1) = 6 → very high. No reliable cohort rate exists for 6+; the tool shows the ≥5 floor (12.50) with an explicit warning.
7 · Frequently asked questions
What is the HAS-BLED score?
HAS-BLED is a 9-factor clinical score developed by Pisters et al. (2010) to estimate the 1-year risk of major bleeding in patients with atrial fibrillation who take anticoagulants. Each risk factor counts 1 point, for a maximum of 9. It is an educational risk-stratification aid, not a diagnosis and not a personal prediction.
What do the letters in HAS-BLED stand for?
H: Hypertension (uncontrolled, systolic blood pressure 160 mmHg or higher). A: Abnormal renal function and Abnormal liver function (1 point each). S: Stroke (prior history). B: Bleeding history or predisposition. L: Labile INRs (unstable INR values, time in therapeutic range below 60%). E: Elderly (age over 65). D: Drugs predisposing to bleeding and alcohol use (1 point each).
How is the HAS-BLED score calculated?
Add 1 point for each of the 9 factors present: uncontrolled hypertension, abnormal renal function, abnormal liver function, prior stroke, bleeding history or predisposition, labile INR, age over 65, bleeding-risk drugs (antiplatelet or NSAID), and alcohol use of 8 or more drinks per week. The total ranges from 0 to 9; renal and liver each score separately, as do drugs and alcohol.
What does my HAS-BLED score mean?
Scores 0-1 indicate low bleeding risk, 2 indicates moderate bleeding risk, and 3 or higher indicates high bleeding risk. In the original derivation cohort (Pisters 2010), major bleeding occurred at 1.13 bleeds per 100 patient-years for score 0, 1.02 for score 1, 1.88 for score 2, 3.74 for score 3, 8.70 for score 4, and 12.50 for score 5. These are cohort estimates, not personal predictions.
Where do the bleeding percentages come from?
The rates shown (1.13, 1.02, 1.88, 3.74, 8.70, 12.50 bleeds per 100 patient-years for scores 0-5) come from the Euro Heart Survey derivation cohort of 3,978 real-world atrial fibrillation patients reported by Pisters et al. in 2010 and reproduced by Lip et al. in 2011. They describe what happened in that study population and should be read as cohort estimates, not as your personal bleeding probability. Scores of 6-9 had too few patients (2 patients at score 6 with 0 bleeds, none at 7-9) for a reliable estimate.
Does a high HAS-BLED score mean I should stop blood thinners?
No. Guidelines (including ESC) position a high HAS-BLED score as a prompt to review and correct modifiable bleeding factors and to follow the patient more closely — not as a reason to withhold anticoagulation on its own. Many patients with a high bleeding score also have a high stroke risk and still benefit from anticoagulation. Never start, stop, or change anticoagulation based on a calculator; that decision belongs to you and your clinician.
Which HAS-BLED factors can actually be changed?
Four of the nine factors are potentially modifiable: uncontrolled hypertension (improve blood-pressure control), labile INR (stabilise anticoagulation control, with clinician review of the agent and monitoring), bleeding-risk drugs (review whether concomitant antiplatelet or NSAID therapy is still needed), and alcohol use (reduce intake). Renal impairment, liver disease, prior stroke, bleeding history, and age over 65 cannot be reversed, but recognising them helps clinicians plan safer care.
HAS-BLED vs CHA2DS2-VASc — what is the difference?
They answer two different questions about the same patient. CHA2DS2-VASc estimates stroke risk in atrial fibrillation (the danger of not anticoagulating), while HAS-BLED estimates major-bleeding risk on anticoagulation (the danger of anticoagulating). In practice both scores are calculated together: a high stroke score with a low bleeding score favours anticoagulation, while a high bleeding score calls for correcting modifiable factors and closer follow-up rather than automatically refusing anticoagulation.
Who should use this HAS-BLED calculator?
It is built for education: clinicians and students who want a quick HAS-BLED tally, and informed patients who want to understand what their care team means by bleeding risk. It does not diagnose atrial fibrillation, does not assess stroke risk (use a CHA2DS2-VASc calculator for that), and does not replace clinical judgment.
What are the limitations of the HAS-BLED score?
The score was derived from a 2010 cohort in the warfarin era, so absolute bleeding rates may differ with modern direct oral anticoagulants and contemporary care. Estimates for scores 6-9 rest on almost no patients and are unreliable. Individual items (for example, what counts as predisposition to bleeding) require clinical interpretation. The score supports, but never replaces, a clinician's judgment about antithrombotic therapy.
Free tool by NRTechStudio